Literature DB >> 3220466

Mucin profiles in ulcerative colitis with dysplasia and carcinoma.

D C Allen1, N S Connolly, J D Biggart.   

Abstract

Mucin secretion was assessed in Crohn's colitis, in ulcerative colitis with regeneration, dysplasia and carcinoma and in non-colitic adenocarcinoma. The high iron diamine-alcian blue (HID-AB) and periodate borohydride-saponification periodic acid Schiff (PB-KOH-PAS) techniques were used to demonstrate sulphomucins and sialomucins, and O-acylated sialomucins respectively. There was mucosal hyperplasia and increased sialomucin secretion in Crohn's disease, quiescent and active ulcerative colitis. In colitis with carcinoma inflamed mucosa away from the tumour had increased sialomucins as had colitis with dysplasia. They did not differ statistically from each other or from colitic controls without cancer. Dysplastic crypts frequently secreted sulphomucins and the increased sialomucins were in transitional-like glands in the surface fronds or adjacent to the dysplasia. A comparative study of the HID-AB technique gave total correct qualitative allocation of individual quantitatively assessed crypts. Routine HID-AB staining did not aid the recognition of dysplasia in ulcerative colitis. With the PB-KOH-PAS technique colorectal adenocarcinoma showed a significant diminution in O-acylated sialomucins compared with its adjacent mucosa. Mucosal dysplasia in ulcerative colitis displayed a similar trend in O-acylated sialic acid variants, differing with respect to age-and sex-matched colitic controls. The PB-KOH-PAS technique may be of help in assessing mucin secretion in ulcerative colitis as a guide to the evolution of malignancy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3220466     DOI: 10.1111/j.1365-2559.1988.tb02057.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

Review 1.  Colonoscopic surveillance in ulcerative colitis--dysplasia through the looking glass.

Authors:  J B Fozard; M F Dixon
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

2.  Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.

Authors:  Melissa J Puppa; James P White; Shuichi Sato; Mark Cairns; John W Baynes; James A Carson
Journal:  Biochim Biophys Acta       Date:  2011-09-02

3.  MUC2 is the prominent colonic mucin expressed in ulcerative colitis.

Authors:  K M Tytgat; F J Opdam; A W Einerhand; H A Büller; J Dekker
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

4.  Distribution of O-acetylated sialomucin in the normal and diseased gastrointestinal tract shown by a new monoclonal antibody.

Authors:  J D Milton; D Eccleston; N Parker; A Raouf; C Cubbin; J Hoffman; C A Hart; J M Rhodes
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

5.  Is the colon mucosa affected by ten days of gastric restriction in an animal model?

Authors:  Flávia Emi Akamatsu; Luiz Gustavo Fontes; Ana Maria Itezerote; Samir Saleh; Walcy Paganelli Rosolia Teodoro; Everson Artifon; Flávio Hojaij; Mauro Andrade; José Aires Pereira; Carlos Augusto Real Martinez; Alfredo Luiz Jacomo
Journal:  Acta Cir Bras       Date:  2019-08-19       Impact factor: 1.388

Review 6.  Proliferation and differentiation biomarkers in colorectal mucosa and their application to chemoprevention studies.

Authors:  A Scalmati; M Lipkin
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

7.  The Histochemical Alterations of Mucin in Colorectal Carcinoma Quantified by Two Efficient Algorithms of Digital Image Analysis.

Authors:  Aldona Kasprzak; Agnieszka Seraszek-Jaros; Joanna Jagielska; Celina Helak-Łapaj; Elżbieta Siodła; Jacek Szmeja; Elżbieta Kaczmarek
Journal:  Int J Mol Sci       Date:  2019-09-16       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.